

Our HPAPI dedicated suite is SafeBridge®-certified and includes a power handling isolator that enables operation at OEL 0.1 – 1.0 µg/m3 (OEB-5).
For your pre-clinical and Phase I demands, our HPAPI capabilities offer route design, process invention and characterisation, crystallisation, isolation and drying, analytical method development and sample analysis, and up to 10g scale non-GMP material supply.
Our powder handling isolator includes a parallel reactor workstation technology, compatible with PAT and automated sampling. This can be used for designed experimentation that can be either data-driven or mechanism-guided.
Route design
Process invention & characterisation
Crystallisation, isolation & drying
Analytical method development & sample analysis
Up to 10g-scale non-GMP material supply
SafeBridge®-certified laboratory
Parallel reactor workstation technology
Process data collection
Up to 10g-scale non-GMP material supply
Analytical method development & sample analysis
SafeBridge®-certified laboratory